Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: experiences from the phase IV PreFace trial

Patients with hormone receptor-positive (HRpos), HER2-negative (HER2neg) breast cancer (BC) benefit less from neoadjuvant chemotherapy (NACT) than patients with triple-negative and HER2-positive BC. In this retrospective analysis of the phase IV PreFace clinical trial (NCT01908556), where postmenopa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Beierlein, Milena (VerfasserIn) , Häberle, Lothar (VerfasserIn) , Nabieva, Naiba (VerfasserIn) , Maass, Nicolai (VerfasserIn) , Aktas, Bahriye (VerfasserIn) , Kümmel, Sherko (VerfasserIn) , Thomssen, Christoph (VerfasserIn) , Wolf, Christopher (VerfasserIn) , Kolberg, Hans-Christian (VerfasserIn) , Brucker, Cosima (VerfasserIn) , Janni, Wolfgang (VerfasserIn) , Dall, Peter (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Marmé, Frederik (VerfasserIn) , Sütterlin, Marc (VerfasserIn) , Ruebner, Matthias (VerfasserIn) , Theuser, Anna-Katharin (VerfasserIn) , Hofmann, Nadine M. (VerfasserIn) , Böhm, Sybille (VerfasserIn) , Almstedt, Katrin (VerfasserIn) , Kellner, Sara (VerfasserIn) , Gass, Paul (VerfasserIn) , Lück, Hans-Joachim (VerfasserIn) , Hein, Alexander (VerfasserIn) , Schmatloch, Sabine (VerfasserIn) , Kalder, Matthias (VerfasserIn) , Uleer, Christoph (VerfasserIn) , Juhasz-Böss, Ingolf (VerfasserIn) , Hanf, Volker (VerfasserIn) , Jackisch, Christian (VerfasserIn) , Müller, Volkmar (VerfasserIn) , Rack, Brigitte (VerfasserIn) , Belleville, Erik (VerfasserIn) , Wallwiener, Diethelm (VerfasserIn) , Rody, Achim (VerfasserIn) , Rauh, Claudia (VerfasserIn) , Bayer, Chistian M. (VerfasserIn) , Uhrig, Sabrina (VerfasserIn) , Huebner, Hanna (VerfasserIn) , Goossens, Chloë (VerfasserIn) , Brucker, Sara (VerfasserIn) , Hack, Carolin C. (VerfasserIn) , Fehm, Tanja (VerfasserIn) , Fasching, Peter Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2025
In: International journal of cancer
Year: 2025, Jahrgang: 157, Heft: 11, Pages: 2363-2373
ISSN:1097-0215
DOI:10.1002/ijc.70037
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ijc.70037
Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.70037
Resolving-System, kostenfrei: https://doi.org/10.25673/120877
Volltext
Verfasserangaben:Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans-Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna-Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans-Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz-Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching

MARC

LEADER 00000caa a2200000 c 4500
001 1932452362
003 DE-627
005 20251127233331.0
007 cr uuu---uuuuu
008 250804s2025 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.70037  |2 doi 
024 7 |a 10.25673/120877  |2 doi 
035 |a (DE-627)1932452362 
035 |a (DE-599)KXP1932452362 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Beierlein, Milena  |e VerfasserIn  |0 (DE-588)1370604475  |0 (DE-627)1929725094  |4 aut 
245 1 0 |a Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole  |b experiences from the phase IV PreFace trial  |c Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans-Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna-Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans-Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz-Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching 
264 1 |c 2025 
300 |b Illustrationen, Diagramme 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Erstmals veröffentlicht: 11. Juli 2025 
500 |a Gesehen am 28.08.2025 
520 |a Patients with hormone receptor-positive (HRpos), HER2-negative (HER2neg) breast cancer (BC) benefit less from neoadjuvant chemotherapy (NACT) than patients with triple-negative and HER2-positive BC. In this retrospective analysis of the phase IV PreFace clinical trial (NCT01908556), where postmenopausal HRpos BC patients (n = 3297) were treated with 5-year upfront adjuvant letrozole therapy, we evaluated the prognosis of patients treated with adjuvant versus neoadjuvant chemotherapy in HRpos/HER2neg early-stage BC. HRpos/HER2neg patients with information on (neo)adjuvant chemotherapy (n = 2895) were retrospectively selected from all patients enrolled in the PreFace trial. Invasive disease-free survival (iDFS) and overall survival (OS) were compared between patient groups that were treated with neoadjuvant or adjuvant chemotherapy. Chemotherapy was given to 1051 patients (36.3% of all patients), of which 874 (83.2%) received adjuvant chemotherapy and 177 (16.8%) NACT. Pathologic complete response (pCR) rate in the NACT group was 6.9%. Patients treated with NACT had a worse outcome than those treated with adjuvant chemotherapy (5-year iDFS rate 81% vs. 88%; 5-year OS rate 89% vs. 93%). This effect was maintained after adjusting for age, BMI, lymph node status, grading, tumor size, and histology (hazard ratio for iDFS: 1.95 (95%CI: 1.28-2.95); hazard ratio for OS: 2.13 (95%CI: 1.24-3.66)). Further adjustment for taxane-based regimes did not alter results. In conclusion, in this retrospective analysis of patients with early-stage HRpos/HER2neg BC, patients with NACT had a more unfavorable prognosis than patients treated adjuvantly, independent of patient and tumor characteristics. Prognosis of neoadjuvant patients might be affected by resistance mechanisms, warranting further investigation. 
540 |q DE-3  |a Namensnennung 4.0 International  |f CC BY 4.0  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
650 4 |a adjuvant chemotherapy 
650 4 |a breast cancer 
650 4 |a hormone receptor-positive/HER2-negative 
650 4 |a neoadjuvant chemotherapy 
650 4 |a phase IV clinical trial 
700 1 |a Häberle, Lothar  |e VerfasserIn  |4 aut 
700 1 |a Nabieva, Naiba  |e VerfasserIn  |4 aut 
700 1 |a Maass, Nicolai  |e VerfasserIn  |4 aut 
700 1 |a Aktas, Bahriye  |e VerfasserIn  |4 aut 
700 1 |a Kümmel, Sherko  |e VerfasserIn  |4 aut 
700 1 |a Thomssen, Christoph  |e VerfasserIn  |0 (DE-588)1207932027  |0 (DE-627)1694239217  |4 aut 
700 1 |a Wolf, Christopher  |e VerfasserIn  |4 aut 
700 1 |a Kolberg, Hans-Christian  |e VerfasserIn  |4 aut 
700 1 |a Brucker, Cosima  |e VerfasserIn  |4 aut 
700 1 |a Janni, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Dall, Peter  |e VerfasserIn  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
700 1 |a Sütterlin, Marc  |d 1967-  |e VerfasserIn  |0 (DE-588)102644067X  |0 (DE-627)72673389X  |0 (DE-576)371782651  |4 aut 
700 1 |a Ruebner, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Theuser, Anna-Katharin  |e VerfasserIn  |4 aut 
700 1 |a Hofmann, Nadine M.  |e VerfasserIn  |4 aut 
700 1 |a Böhm, Sybille  |e VerfasserIn  |4 aut 
700 1 |a Almstedt, Katrin  |e VerfasserIn  |4 aut 
700 1 |a Kellner, Sara  |e VerfasserIn  |4 aut 
700 1 |a Gass, Paul  |e VerfasserIn  |4 aut 
700 1 |a Lück, Hans-Joachim  |e VerfasserIn  |4 aut 
700 1 |a Hein, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Schmatloch, Sabine  |e VerfasserIn  |4 aut 
700 1 |a Kalder, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Uleer, Christoph  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Juhasz-Böss, Ingolf  |e VerfasserIn  |0 (DE-588)1166064549  |0 (DE-627)1029976902  |0 (DE-576)510596789  |4 aut 
700 1 |a Hanf, Volker  |e VerfasserIn  |4 aut 
700 1 |a Jackisch, Christian  |e VerfasserIn  |4 aut 
700 1 |a Müller, Volkmar  |e VerfasserIn  |4 aut 
700 1 |a Rack, Brigitte  |e VerfasserIn  |4 aut 
700 1 |a Belleville, Erik  |e VerfasserIn  |4 aut 
700 1 |a Wallwiener, Diethelm  |e VerfasserIn  |4 aut 
700 1 |a Rody, Achim  |e VerfasserIn  |4 aut 
700 1 |a Rauh, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Bayer, Chistian M.  |e VerfasserIn  |4 aut 
700 1 |a Uhrig, Sabrina  |e VerfasserIn  |4 aut 
700 1 |a Huebner, Hanna  |e VerfasserIn  |4 aut 
700 1 |a Goossens, Chloë  |e VerfasserIn  |4 aut 
700 1 |a Brucker, Sara  |d 1974-  |e VerfasserIn  |0 (DE-588)122129660  |0 (DE-627)081754264  |0 (DE-576)293107386  |4 aut 
700 1 |a Hack, Carolin C.  |e VerfasserIn  |4 aut 
700 1 |a Fehm, Tanja  |d 1971-  |e VerfasserIn  |0 (DE-588)120391759  |0 (DE-627)080645690  |0 (DE-576)292194064  |4 aut 
700 1 |a Fasching, Peter Andreas  |d 1975-  |e VerfasserIn  |0 (DE-588)129068780  |0 (DE-627)388703040  |0 (DE-576)297477099  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 157(2025), 11, Seite 2363-2373  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole experiences from the phase IV PreFace trial 
773 1 8 |g volume:157  |g year:2025  |g number:11  |g pages:2363-2373  |a Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole experiences from the phase IV PreFace trial 
856 4 0 |u https://doi.org/10.1002/ijc.70037  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.70037  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://doi.org/10.25673/120877  |x Resolving-System  |z kostenfrei 
883 |8 1\p  |a cgwrk  |d 20251101  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20250828 
993 |a Article 
994 |a 2025 
998 |g 102644067X  |a Sütterlin, Marc  |m 102644067X:Sütterlin, Marc  |d 60000  |d 61300  |e 60000PS102644067X  |e 61300PS102644067X  |k 0/60000/  |k 1/60000/61300/  |p 15 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 60000  |d 61300  |d 50000  |e 60000PM132561972  |e 61300PM132561972  |e 50000PM132561972  |k 0/60000/  |k 1/60000/61300/  |k 0/50000/  |p 14 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 13 
999 |a KXP-PPN1932452362  |e 4765075184 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","display":"Beierlein, Milena","given":"Milena","family":"Beierlein"},{"display":"Häberle, Lothar","given":"Lothar","family":"Häberle","role":"aut"},{"role":"aut","given":"Naiba","display":"Nabieva, Naiba","family":"Nabieva"},{"family":"Maass","given":"Nicolai","display":"Maass, Nicolai","role":"aut"},{"role":"aut","given":"Bahriye","display":"Aktas, Bahriye","family":"Aktas"},{"role":"aut","display":"Kümmel, Sherko","given":"Sherko","family":"Kümmel"},{"role":"aut","family":"Thomssen","display":"Thomssen, Christoph","given":"Christoph"},{"given":"Christopher","display":"Wolf, Christopher","family":"Wolf","role":"aut"},{"role":"aut","family":"Kolberg","given":"Hans-Christian","display":"Kolberg, Hans-Christian"},{"family":"Brucker","display":"Brucker, Cosima","given":"Cosima","role":"aut"},{"family":"Janni","given":"Wolfgang","display":"Janni, Wolfgang","role":"aut"},{"given":"Peter","display":"Dall, Peter","family":"Dall","role":"aut"},{"given":"Andreas","display":"Schneeweiss, Andreas","family":"Schneeweiss","role":"aut"},{"family":"Marmé","given":"Frederik","display":"Marmé, Frederik","role":"aut"},{"role":"aut","given":"Marc","display":"Sütterlin, Marc","family":"Sütterlin"},{"role":"aut","family":"Ruebner","given":"Matthias","display":"Ruebner, Matthias"},{"given":"Anna-Katharin","display":"Theuser, Anna-Katharin","family":"Theuser","role":"aut"},{"display":"Hofmann, Nadine M.","given":"Nadine M.","family":"Hofmann","role":"aut"},{"role":"aut","family":"Böhm","display":"Böhm, Sybille","given":"Sybille"},{"given":"Katrin","display":"Almstedt, Katrin","family":"Almstedt","role":"aut"},{"family":"Kellner","display":"Kellner, Sara","given":"Sara","role":"aut"},{"role":"aut","display":"Gass, Paul","given":"Paul","family":"Gass"},{"family":"Lück","given":"Hans-Joachim","display":"Lück, Hans-Joachim","role":"aut"},{"role":"aut","family":"Hein","given":"Alexander","display":"Hein, Alexander"},{"family":"Schmatloch","display":"Schmatloch, Sabine","given":"Sabine","role":"aut"},{"family":"Kalder","given":"Matthias","display":"Kalder, Matthias","role":"aut"},{"role":"aut","given":"Christoph","display":"Uleer, Christoph","family":"Uleer"},{"family":"Juhasz-Böss","given":"Ingolf","display":"Juhasz-Böss, Ingolf","role":"aut"},{"display":"Hanf, Volker","given":"Volker","family":"Hanf","role":"aut"},{"role":"aut","family":"Jackisch","display":"Jackisch, Christian","given":"Christian"},{"family":"Müller","display":"Müller, Volkmar","given":"Volkmar","role":"aut"},{"given":"Brigitte","display":"Rack, Brigitte","family":"Rack","role":"aut"},{"role":"aut","family":"Belleville","display":"Belleville, Erik","given":"Erik"},{"role":"aut","display":"Wallwiener, Diethelm","given":"Diethelm","family":"Wallwiener"},{"role":"aut","family":"Rody","given":"Achim","display":"Rody, Achim"},{"role":"aut","family":"Rauh","given":"Claudia","display":"Rauh, Claudia"},{"display":"Bayer, Chistian M.","given":"Chistian M.","family":"Bayer","role":"aut"},{"role":"aut","given":"Sabrina","display":"Uhrig, Sabrina","family":"Uhrig"},{"given":"Hanna","display":"Huebner, Hanna","family":"Huebner","role":"aut"},{"family":"Goossens","display":"Goossens, Chloë","given":"Chloë","role":"aut"},{"role":"aut","family":"Brucker","given":"Sara","display":"Brucker, Sara"},{"role":"aut","display":"Hack, Carolin C.","given":"Carolin C.","family":"Hack"},{"display":"Fehm, Tanja","given":"Tanja","family":"Fehm","role":"aut"},{"given":"Peter Andreas","display":"Fasching, Peter Andreas","family":"Fasching","role":"aut"}],"recId":"1932452362","name":{"displayForm":["Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans-Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna-Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans-Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz-Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"2025"}],"language":["eng"],"title":[{"title_sort":"Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole","subtitle":"experiences from the phase IV PreFace trial","title":"Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole"}],"physDesc":[{"noteIll":"Illustrationen, Diagramme"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1932452362"],"doi":["10.1002/ijc.70037","10.25673/120877"]},"relHost":[{"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["269532781"],"doi":["10.1002/(ISSN)1097-0215"],"issn":["1097-0215"],"zdb":["1474822-8"]},"part":{"text":"157(2025), 11, Seite 2363-2373","volume":"157","pages":"2363-2373","issue":"11","year":"2025"},"title":[{"title":"International journal of cancer","title_sort":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer"}],"origin":[{"dateIssuedDisp":"1966-","publisher":"Wiley-Liss","publisherPlace":"Bognor Regis","dateIssuedKey":"1966"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"corporate":[{"display":"International Union against Cancer","role":"isb"}],"pubHistory":["1.1966 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"titleAlt":[{"title":"Predictive oncology"}],"disp":"Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole experiences from the phase IV PreFace trialInternational journal of cancer","recId":"269532781"}],"note":["Erstmals veröffentlicht: 11. Juli 2025","Gesehen am 28.08.2025"]} 
SRT |a BEIERLEINMINVASIVEDI2025